Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Feb;64(2):172–177. doi: 10.1136/jnnp.64.2.172

Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers

V Hahn-Barma 1, B Deweer 1, A Durr 1, C Dode 1, J Feingold 1, B Pillon 1, Y Agid 1, A Brice 1, B Dubois 1
PMCID: PMC2169968  PMID: 9489526

Abstract

BACKGROUND—Huntington's disease is a neurodegenerative disorder due to an excessive number of CAG repeats in the IT15 gene on chromosome 4. The first symptoms are typically choreic movements or psychiatric disorders, whereas global cognitive decline generally becomes obvious later. This study was aimed at detecting early subtle cognitive deficits in asymptomatic gene carriers.
METHODS—As part of the testing procedure for predictive diagnosis of Huntington's disease, 91 asymptomatic at risk candidates had a neuropsychological examination, evaluating global efficiency, attention, memory (Wechsler memory scale and California verbal learning test), and executive functions.
RESULTS—The groups of carriers (n=42) and non-carriers (n=49) differed only on a few memory variables. When we considered the group of gene carriers as a whole, significant correlations emerged between the number of CAG repeats and (a) performance on several tests of executive functions, and (b) performance on the hard pairs associates of the Wechsler memory scale. Further analysis of performance on this memory subtest led to the division of the group of carriers into two subgroups, without any overlap. The performance of subjects without cognitive deficits (n=32) was similar to that of non-carriers on all tests. The subjects with cognitive deficits (n=10) differed from both carriers without cognitive deficits and non-carriers over a wide array of variables measuring executive functions and memory. Moreover, qualitative aspects of the performance of carriers with cognitive deficits in the California verbal learning test closely resembled those of patients diagnosed as having Huntington's disease.
Conclusion—This suggests that these subjects already have Huntington's disease, despite a total lack of motor and psychiatric signs. An ongoing follow up study is testing the prediction that they will develop the full range of symptoms of the disease earlier than carriers without cognitive deficits.



Full Text

The Full Text of this article is available as a PDF (104.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackmore L., Simpson S. A., Crawford J. R. Cognitive performance in UK sample of presymptomatic people carrying the gene for Huntington's disease. J Med Genet. 1995 May;32(5):358–362. doi: 10.1136/jmg.32.5.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brandt J., Strauss M. E., Larus J., Jensen B., Folstein S. E., Folstein M. F. Clinical correlates of dementia and disability in Huntington's disease. J Clin Neuropsychol. 1984 Nov;6(4):401–412. doi: 10.1080/01688638408401231. [DOI] [PubMed] [Google Scholar]
  3. Butters N., Granholm E., Salmon D. P., Grant I., Wolfe J. Episodic and semantic memory: a comparison of amnesic and demented patients. J Clin Exp Neuropsychol. 1987 Oct;9(5):479–497. doi: 10.1080/01688638708410764. [DOI] [PubMed] [Google Scholar]
  4. Butters N., Sax D., Montgomery K., Tarlow S. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch Neurol. 1978 Sep;35(9):585–589. doi: 10.1001/archneur.1978.00500330033006. [DOI] [PubMed] [Google Scholar]
  5. Cardebat D., Doyon B., Puel M., Goulet P., Joanette Y. Evocation lexicale formelle et sémantique chez des sujets normaux. Performances et dynamiques de production en fonction du sexe, de l'âge et du niveau d'étude. Acta Neurol Belg. 1990;90(4):207–217. [PubMed] [Google Scholar]
  6. Diamond R., White R. F., Myers R. H., Mastromauro C., Koroshetz W. J., Butters N., Rothstein D. M., Moss M. B., Vasterling J. Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol. 1992 Nov;14(6):961–975. doi: 10.1080/01688639208402547. [DOI] [PubMed] [Google Scholar]
  7. Dodé C., Dürr A., Pêcheux C., Mouret J. F., Belal S., Bachner L., Agid Y., Kaplan J. C., Brice A., Feingold J. Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis. C R Acad Sci III. 1993 Nov;316(11):1374–1380. [PubMed] [Google Scholar]
  8. Dürr A., Dodé C., Hahn V., Pêcheux C., Pillon B., Feingold J., Kaplan J. C., Agid Y., Brice A. Diagnosis of "sporadic" Huntington's disease. J Neurol Sci. 1995 Mar;129(1):51–55. doi: 10.1016/0022-510x(94)00250-r. [DOI] [PubMed] [Google Scholar]
  9. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  10. Foroud T., Siemers E., Kleindorfer D., Bill D. J., Hodes M. E., Norton J. A., Conneally P. M., Christian J. C. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol. 1995 May;37(5):657–664. doi: 10.1002/ana.410370516. [DOI] [PubMed] [Google Scholar]
  11. Giordani B., Berent S., Boivin M. J., Penney J. B., Lehtinen S., Markel D. S., Hollingsworth Z., Butterbaugh G., Hichwa R. D., Gusella J. F. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol. 1995 Jan;52(1):59–64. doi: 10.1001/archneur.1995.00540250063014. [DOI] [PubMed] [Google Scholar]
  12. Guidelines for the molecular genetics predictive test in Huntington's disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology. 1994 Aug;44(8):1533–1536. [PubMed] [Google Scholar]
  13. Jason G. W., Pajurkova E. M., Suchowersky O., Hewitt J., Hilbert C., Reed J., Hayden M. R. Presymptomatic neuropsychological impairment in Huntington's disease. Arch Neurol. 1988 Jul;45(7):769–773. doi: 10.1001/archneur.1988.00520310079021. [DOI] [PubMed] [Google Scholar]
  14. Josiassen R. C., Curry L. M., Mancall E. L. Development of neuropsychological deficits in Huntington's disease. Arch Neurol. 1983 Dec;40(13):791–796. doi: 10.1001/archneur.1983.04050120041005. [DOI] [PubMed] [Google Scholar]
  15. Josiassen R. C., Curry L., Roemer R. A., DeBease C., Mancall E. L. Patterns of intellectual deficit in Huntington's disease. J Clin Neuropsychol. 1982 Jul;4(2):173–183. doi: 10.1080/01688638208401127. [DOI] [PubMed] [Google Scholar]
  16. Kuhl D. E., Metter E. J., Riege W. H., Markham C. H. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann Neurol. 1984;15 (Suppl):S119–S125. doi: 10.1002/ana.410150723. [DOI] [PubMed] [Google Scholar]
  17. Kuhl D. E., Phelps M. E., Markham C. H., Metter E. J., Riege W. H., Winter J. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol. 1982 Nov;12(5):425–434. doi: 10.1002/ana.410120504. [DOI] [PubMed] [Google Scholar]
  18. Lange K. W., Sahakian B. J., Quinn N. P., Marsden C. D., Robbins T. W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry. 1995 May;58(5):598–606. doi: 10.1136/jnnp.58.5.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lawrence A. D., Sahakian B. J., Hodges J. R., Rosser A. E., Lange K. W., Robbins T. W. Executive and mnemonic functions in early Huntington's disease. Brain. 1996 Oct;119(Pt 5):1633–1645. doi: 10.1093/brain/119.5.1633. [DOI] [PubMed] [Google Scholar]
  20. Massman P. J., Delis D. C., Butters N., Levin B. E., Salmon D. P. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol. 1990 Oct;12(5):729–744. doi: 10.1080/01688639008401015. [DOI] [PubMed] [Google Scholar]
  21. Mazziotta J. C., Phelps M. E., Pahl J. J., Huang S. C., Baxter L. R., Riege W. H., Hoffman J. M., Kuhl D. E., Lanto A. B., Wapenski J. A. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med. 1987 Feb 12;316(7):357–362. doi: 10.1056/NEJM198702123160701. [DOI] [PubMed] [Google Scholar]
  22. Montgomery S. A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979 Apr;134:382–389. doi: 10.1192/bjp.134.4.382. [DOI] [PubMed] [Google Scholar]
  23. Pillon B., Deweer B., Agid Y., Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol. 1993 Apr;50(4):374–379. doi: 10.1001/archneur.1993.00540040036010. [DOI] [PubMed] [Google Scholar]
  24. Pillon B., Dubois B., Ploska A., Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology. 1991 May;41(5):634–643. doi: 10.1212/wnl.41.5.634. [DOI] [PubMed] [Google Scholar]
  25. Rothlind J. C., Brandt J., Zee D., Codori A. M., Folstein S. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease. Arch Neurol. 1993 Aug;50(8):799–802. doi: 10.1001/archneur.1993.00540080010005. [DOI] [PubMed] [Google Scholar]
  26. Smith S., Butters N., White R., Lyon L., Granholm E. Priming semantic relations in patients with Huntington's disease. Brain Lang. 1988 Jan;33(1):27–40. doi: 10.1016/0093-934x(88)90052-1. [DOI] [PubMed] [Google Scholar]
  27. Strauss M. E., Brandt J. Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals? Arch Neurol. 1990 Aug;47(8):905–908. doi: 10.1001/archneur.1990.00530080093016. [DOI] [PubMed] [Google Scholar]
  28. Strauss M. E., Brandt J. Is there increased WAIS pattern variability in Huntington's disease? J Clin Exp Neuropsychol. 1985 Feb;7(1):122–126. doi: 10.1080/01688638508401246. [DOI] [PubMed] [Google Scholar]
  29. el-Awar M., Becker J. T., Hammond K. M., Nebes R. D., Boller F. Learning deficit in Parkinson's disease. Comparison with Alzheimer's disease and normal aging. Arch Neurol. 1987 Feb;44(2):180–184. doi: 10.1001/archneur.1987.00520140048016. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES